Point of care multiplex sepsis test
Sepsis
LaunchingActive
Key Facts
About EDX Medical
EDX Medical is a UK-listed diagnostics company founded in 2019, specializing in precision testing for cancer, cardiovascular, and infectious diseases. Its strategy is built on a hybrid model of in-house development and strategic partnerships, notably with Caris Life Sciences and Thermo Fisher Scientific, to distribute and co-develop advanced molecular profiling and functional assays. The company is transitioning from a distributor to a developer, with a pipeline of novel tests and a planned launch of an advanced bowel cancer service in 2026, positioning itself at the intersection of digital and laboratory-based diagnostics.
View full company profileTherapeutic Areas
Other Sepsis Drugs
| Drug | Company | Phase |
|---|---|---|
| VB-001 | VST Bio | Pre-clinical |
| SIXTIDE | Sepsia Therapeutics | Pre-clinical |
| Injectable Melatonin (IPR-490) | Pharmamel | Phase 2 |
| Ultrasensitive Sepsis Diagnostics | DIANA Biotechnologies | Development/Commercialization |
| EXO‑CD24 | Nano24med | Preclinical |